Preview
Description
Bispecific antibodies are a novel mechanism in the management in the relapsed/refractory multiple myeloma. Recognizing the mechanism of these agents as well as preliminary efficacy data is important in considering clinical trials and implementing approved bispecific antibodies in the management of multiple myeloma.
Technical Analysis
Package Overview Basic metadata
Bundle ID
com.mlg.mmar Current Version 1.0
Minimum iOS 11.0
Package Size App Store Size
Package Metadata 0 / 1 version records
Detailed binary, privacy manifest, framework, and Info.plist results have not been indexed for this package yet. The verified App Store and archive metadata above remains available.
Known Version Records
0 version records with stored package metadata • 1 known version records
Stored metadata does not guarantee a package is currently available to download.
| Details | Version / IDs | Version date | Action |
|---|---|---|---|
| Not archived | App Store ID: 857364449 | Unknown | Request Version |